Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs D Wave Quantum Inc (QBTS) Price & Performance

Intuitive Surgical, Inc.Trade
D Wave Quantum IncTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs D Wave Quantum Inc — how do they compare? Intuitive Surgical, Inc. trades at $424.55 (market cap $146.76B), while D Wave Quantum Inc trades at $14.6 (market cap $5.54B). The key difference: Intuitive Surgical, Inc. is far larger — about 26.5× D Wave Quantum Inc's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and D Wave Quantum Inc for 32 Days on average.

ISRGQBTS
Market Cap
$146.76B$5.54B
Volume
2,529,81416,671,452
Sector
HealthTechnology
52-Week High
$592.85$44.78
52-Week Low
$332.02$12.98
Typical Hold Time
84 Days32 Days
Enterprise Value
$141.54B$5.04B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.

ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.

D Wave Quantum Inc

D-Wave Quantum (QBTS) trades at $14.52, down 4.6% on the day, amid a bearish technical signal and negative earnings trends. The company reported a net loss of $355 million in 2025 on $25 million in revenue, with a deeply negative net income margin. However, all 13 analysts covering the stock maintain a Buy rating with a consensus price target of $34.38, suggesting significant upside potential from current levels.

The outlook is highly speculative, balancing substantial analyst optimism against severe financial losses and ongoing securities investigations. Investment opportunity hinges on the company's ability to commercialize quantum technology, but risks include cash burn, competitive pressures, and legal uncertainties that could impede shareholder value creation.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ISRG
92% Buy8% Sell
Avg holding period · 84 Days
QBTS
90% Buy10% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →

About D Wave Quantum Inc

D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.

Read more on QBTS →